Savara Pharmaceuticals
SVRA
#6616
Rank
HK$4.29 B
Marketcap
HK$25.02
Share price
-1.23%
Change (1 day)
-30.29%
Change (1 year)

Savara Pharmaceuticals (SVRA) - Cash on Hand

Cash on Hand as of September 2024 : HK$1.70 Billion

According to Savara Pharmaceuticals's latest financial reports the company has HK$1.70 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Savara Pharmaceuticals - Cash on Hand chart (from 2002 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31HK$1.26 B28.9%
2022-12-31HK$0.98 B-21.74%
2021-12-31HK$1.25 B97.25%
2020-12-31HK$0.63 B-32.81%
2019-12-31HK$0.94 B9.26%
2018-12-31HK$0.86 B17.78%
2017-12-31HK$0.73 B610.56%
2016-12-31HK$0.10 B-67.35%
2015-12-31HK$0.31 B-28.52%
2014-12-31HK$0.44 B29.09%
2013-12-31HK$0.34 B21.63%
2012-12-31HK$0.28 B-28.14%
2011-12-31HK$0.39 B80.87%
2010-12-31HK$0.21 B223.99%
2009-12-31HK$67.2 M-11.71%
2008-12-31HK$76.11 M-70.83%
2007-12-31HK$0.26 B-35.17%
2006-12-31HK$0.40 B129.75%
2005-12-31HK$0.17 B72.96%
2004-12-31HK$0.10 B209.15%
2003-12-31HK$32.75 M3941.99%
2002-12-31HK$0.81 M-36.81%
2001-12-31HK$1.28 M-88.92%
2000-12-31HK$11.57 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
HK$0.12 B-92.53%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$3.15 B 85.20%๐Ÿ‡บ๐Ÿ‡ธ USA